Enhancing the accumulation of IFN-Υ producing CD8+ Trm in the large intestine in a CXCR3-dependent manner might have important implications for cancer immunotherapy, particularly in the case of colorectal cancer (CRC). This evidence concerns the gene IFNA1 and cancer.